8 insiders reported 12 Form 4 transactions for ATOSSA THERAPEUTICS, INC. (ATOS) over the past 18 months (most recent 2026-05-14). Recent activity: Steinhart Richard I (Director) Buy 10,000 shares, Remmel H. Lawrence (Director) Buy 10,000 shares, Galli Stephen J (Director) Buy 10,000 shares, Chen Shu-Chih (Director) Buy 10,000 shares, Finn Jonathan (Director) Buy 10,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-14 | Steinhart Richard I | Director | Buy | 10,000 | $0 |
| 2026-05-14 | Remmel H. Lawrence | Director | Buy | 10,000 | $0 |
| 2026-05-14 | Galli Stephen J | Director | Buy | 10,000 | $0 |
| 2026-05-14 | Chen Shu-Chih | Director | Buy | 10,000 | $0 |
| 2026-05-14 | Finn Jonathan | Director | Buy | 10,000 | $0 |
| 2026-05-14 | Cigler Tessa | Director | Buy | 10,000 | $0 |
| 2026-03-31 | QUAY STEVEN C | President & CEO | Buy | 65,000 | $0 |
| 2026-03-30 | Daniel Mark James | Chief Financial Officer | Buy | 63,000 | $0 |
| 2026-01-30 | QUAY STEVEN C | President & CEO | Buy | 331,674 | $0 |
| 2026-01-22 | QUAY STEVEN C | President & CEO | Buy | 325,203 | $0 |
| 2025-05-22 | QUAY STEVEN C | President & CEO | Buy | 11,239 | $0 |
| 2025-03-28 | Remmel H. Lawrence | Director | Buy | 10,000 | $0 |
Source: SEC Form 4 filings · as of 2026-05-14